GlassScriptPhysician profile
David Craig Seegmiller
NPI 1619914751
$120,340.71
in general payments reported to CMS, 2019-2025
32 companies · $10K in 2025
The $10K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $10K · 2021: $2,187 · 2022: $16K · 2023: $14K · 2024: $50K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Debt Forgiveness: $30K · Travel and Lodging: $5,012 · Food and Beverage: $1,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,891.25 |
| Debt Forgiveness | $29,600.00 |
| Travel and Lodging | $5,011.69 |
| Food and Beverage | $1,417.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $63,955.16 | 2019-2025 | Truelok, G-Beam Fusion Beaming System, Physio-Stim |
| Convatec INC. | $29,600.00 | 2024 | |
| Stryker Corporation | $16,507.10 | 2020-2025 | Salvation, Hoffmann, Prostep |
| Wright Medical Technology, INC. | $6,748.66 | 2019 | |
| Paragon 28, INC. | $1,618.23 | 2019-2024 | Monkey Bars |
| Sanara Medtech INC. | $239.02 | 2021 | |
| Smith+Nephew, INC. | $174.76 | 2019-2023 | Grafix Pl |
| Paratek Pharmaceuticals, INC. | $170.79 | 2022-2024 | Nuzyra |
| Imbed Biosciences INC. | $161.32 | 2022 | |
| Mimedx Group, INC. | $110.46 | 2024-2025 | |
| Organogenesis INC. | $109.69 | 2019-2022 | |
| Urgo Medical North America, LLC | $100.57 | 2022-2025 | Urgok2 |
| Allergan, INC. | $90.34 | 2019-2020 | |
| Vilex LLC | $87.59 | 2022 | |
| Integra Lifesciences Corporation | $87.29 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $86.97 | 2022 | |
| Treace Medical Concepts, INC. | $70.28 | 2022-2025 | |
| Abbvie INC. | $54.87 | 2021-2023 | Dalvance |
| Horizon Therapeutics Plc | $51.30 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $36.93 | 2019 | |
| Osiris Therapeutics INC. | $34.56 | 2019 | |
| Kci USA, INC. | $34.17 | 2020-2023 | Activ.A.C. |
| Nabriva Therapeutics, Plc | $29.76 | 2022 | |
| Melinta Therapeutics, LLC | $28.41 | 2019 | |
| Nevro Corp. | $25.36 | 2023 | Senza |
| Vertex Pharmaceuticals Incorporated | $24.74 | 2025 | |
| Biocomposites INC | $22.27 | 2025 | Stimulan |
| Aroa Biosurgery Incorporated | $20.03 | 2022 | |
| Solventum Corporation | $17.65 | 2025 | Activ.A.C. |
| Depuy Synthes Sales INC. | $17.65 | 2023 | Fibulink |
| Arthrosurface Incorporated | $13.07 | 2019 | |
| Polynovo North America LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Seegmiller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.